Schramm, Christoph

Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group

Than, N. N., Hodson, J., Schmidt-Martin, D., Taubert, R., Wawman, R. E., Botter, M., Gautam, N., Bock, K., Jones, R., Appanna, G. D., et al. (2019) · JHEP Reports

Liver Diseases and ImmunityIgG4-Related and Inflammatory Diseases

Cited by 101

Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?

Corpechot, C., Lemoinne, S., Soret, P.-A., Hansen, B., Hirschfield, G., Gulamhusein, A., Montano-Loza, A. J., Lytvyak, E., Pares, A., Olivas, I., et al. (2024) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 94

Monocytes as Potential Mediators of Pathogen‐Induced T‐Helper 17 Differentiation in Patients With Primary Sclerosing Cholangitis (PSC)

Kunzmann, L. K., Schoknecht, T., Poch, T., Henze, L., Stein, S., Kriz, M., Grewe, I., Preti, M., Hartl, J., Pannicke, N., et al. (2020) · Hepatology

Liver Diseases and ImmunityInflammatory Bowel Disease

Cited by 93

Low risk of hepatocellular carcinoma in patients with primary sclerosing cholangitis with cirrhosis

Zenouzi, R., Weismüller, T. J., Hübener, P., Schulze, K., Bubenheim, M., Pannicke, N., Weiler–Normann, C., Lenzen, H., Manns, M. P., Lohse, A. W., et al. (2014) · Clinical Gastroenterology and Hepatology

Liver Diseases and ImmunityHepatocellular Carcinoma Treatment and Prognosis

Cited by 86

Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult‐to‐treat primary biliary cholangitis

Soret, P., Lam, L., Carrat, F., Smets, L., Berg, T., Carbone, M., Invernizzi, P., Leroy, V., Trivedi, P., Cazzagon, N., et al. (2021) · Alimentary Pharmacology & Therapeutics

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 78

Pregnancy in primary sclerosing cholangitis

Wellge, B. E., Sterneck, M., Teufel, A., Rust, C., Franke, A., Schreiber, S., Berg, T., Günther, R., Kreisel, W., zu Eulenburg, C., et al. (2011) · Gut

Liver Diseases and ImmunityPregnancy and Medication Impact

Cited by 76

Effects of tumor necrosis factor antagonists in patients with primary sclerosing cholangitis

Hedin, C. R. H., Sado, G., Ndegwa, N., Lytvyak, E., Mason, A., Montano-Loza, A., Gerussi, A., Saffioti, F., Thorburn, D., Nilsson, E., et al. (2020) · Clinical Gastroenterology and Hepatology

Inflammatory Bowel DiseaseLiver Diseases and Immunity

Cited by 52

Anti-glycoprotein 2 (anti-GP2) IgA and anti-neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3-ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis

Wunsch, E., Norman, G. L., Milkiewicz, M., Krawczyk, M., Bentow, C., Shums, Z., Mahler, M., Lopens, S., Reinhold, D., Franke, A., et al. (2021) · Alimentary Pharmacology & Therapeutics

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 43

Efficacy of a Brief, Peer-Delivered Self-management Intervention for Patients With Rare Chronic Diseases: A Randomized Clinical Trial

Depping, M. K., Uhlenbusch, N., Härter, M., Schramm, C., & Löwe, B. (2021) · JAMA Psychiatry

Mental Health and Patient InvolvementDiabetes Management and Education

Cited by 43

Th17 cell frequency is associated with low bone mass in primary sclerosing cholangitis

Schmidt, T., Schwinge, D., Rolvien, T., Jeschke, A., Schmidt, C., Neven, M., Butscheidt, S., Kriz, M., Kunzmann, L., Mussawy, H., et al. (2019) · Journal of Hepatology

Liver Diseases and ImmunityBone health and osteoporosis research

Cited by 42

Nanoparticle‐mediated targeting of autoantigen peptide to cross‐presenting liver sinusoidal endothelial cells protects from CD8 T‐cell‐driven autoimmune cholangitis

Carambia, A., Gottwick, C., Schwinge, D., Stein, S., Digigow, R., Şeleci, M., Mungalpara, D., Heine, M., Schuran, F. A., Corban, C., et al. (2021) · Immunology

Liver Diseases and ImmunityImmunotherapy and Immune Responses

Cited by 30

Cell-autonomous hepatocyte-specific GP130 signaling is sufficient to trigger a robust innate immune response in mice

Schumacher, N., Yan, K., Gandraß, M., Müller, M., Krisp, C., Häsler, R., Carambia, A., Nofer, J.-R., Bernardes, J. P., Khouja, M., et al. (2021) · Journal of Hepatology

Cytokine Signaling Pathways and InteractionsLiver physiology and pathology

Cited by 24

Litomosoides sigmodontis induces TGF‐β receptor responsive, IL‐10‐producing T cells that suppress bystander T‐cell proliferation in mice

Hartmann, W., Schramm, C., & Breloer, M. (2015) · European Journal of Immunology

Parasites and Host InteractionsParasitic Diseases Research and Treatment

Cited by 22

Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis

Peiseler, M., Reiners, D., Pinnschmidt, H. O., Sebode, M., Jung, F., Hartl, J., Zenouzi, R., Ehlken, H., Groth, S., Schachschal, G., et al. (2018) · PLOS ONE

Liver Diseases and ImmunityGallbladder and Bile Duct Disorders

Cited by 17

Diffusion-weighted MRI for detection of hepatic osteodystrophy in primary sclerosing cholangitis: a comparison study with dual-energy X-ray absorptiometry

Keller, S., Ittrich, H., Schramm, C., Lohse, A. W., Amling, M., Adam, G., & Yamamura, J. (2016) · Japanese Journal of Radiology

Liver Diseases and ImmunityAdvanced MRI Techniques and Applications

Cited by 4